Purdue Pharma in Planning to Settle Lawsuits with 10-12 Billion USD

Purdue Pharma, the pharmaceutical giant that makes OxyContin, and its owners, the wealthy Sackler family, are in talks to settle over 2,000 lawsuits aimed at the company for the opioid crisis. Preliminary discussions are in the range of $10 billion to $12 billion. Which Lawsuits Are Involved? The 2,000 lawsuits stem from cities, counties, and states that have suffered from the opioid crisis for years. The current suit in which settlement talks are being made is in Ohio. The pharmaceutical company wants to consolidate the lawsuits and have the affected parties decide who gets what in terms of settlement talks. The lawsuit payouts are part of confidential conversations and discussed by Purdue's lawyers at a meeting in Cleveland last Tuesday, Aug. 20, according to NBC news. What Are the Lawsuits About? The lawsuits point blame to Perdue Pharma and the Sackler family ignoring the harmful prospects of addiction, downplaying the addictiveness of their drug to doctors, and encouraging the doctors to increase prescriptions for their medications. Purdue Pharma and…

Continue Reading

Drug Distributor McKesson Settles WV Opioid Lawsuit

McKesson, a drug distribution giant, has decided to settle a lawsuit in West Virginia with a 37 million dollar settlement. The company paid $14.5 million upon settling and will pay another $4.5 million a year for the next five years. About the Lawsuit The original lawsuit accused the drug distributor of turning a willfully blind eye to suspicious behavior. Many opioid distributors have been charged with ignoring abnormally large orders, such as massive amounts of pills sent to different pharmacies across the state repeatedly. When irregularities were noted, the company did nothing to investigate. As part of the settlement, McKesson did not have to admit any wrongdoings. McKesson’s Ongoing Trouble This lawsuit is not the company’s first lawsuit for its practices regarding opioids. In 2017, the McKesson paid $150 million in penalties. They were forced to suspend sales of opioids in Colorado, Ohio, Michigan, and Florida after being accused of violating the Controlled Substances Act (CSA). McKesson agreed with the federal government to make “improvements” to its system. Alongside…

Continue Reading

Florida Sues CVS and Walgreens Over Opioids

The state of Florida has announced it is suing Walgreens and CVS, blaming them for the local and national opioid crisis. They say the two retailers, who also happen to be the most significant two pharmacy chains in the US, helped create the crisis by “overselling painkillers” and not taking actions that would help stop the increasing illegal sales once the opioids left the pharmacy. In essence, they are being accused by the government of turning a blind eye to the opioid crisis. The lawsuit isn’t a new lawsuit, but rather an amended lawsuit filed by Attorney General Pam Bondi. The lawsuit also points fingers to Purdue Pharma, the maker of OxyContin, and several opioid distributors. All of these entities, she says, profited as they willfully turned blind eyes to the addiction epidemic. In Bondi’s press release, she alleges that CVS and Walgreens "played a role in creating the opioid crisis." By failing to halt "suspicious orders of opioids," the two stores then "dispensed unreasonable quantities of opioids from…

Continue Reading

Oxycontin Manufacturer Helped Write the Laws it Claims Justify Marketing

Mired in lawsuits, Oxycontin manufacturer Perdue Pharma is quick to deflect blame when it comes to the opioid crisis. Marketing tactics such as paying doctors to do little more than discuss the drug with their colleagues and pushing the drug to ER physicians were all legal, according to the company. But is this reality, or are these the pleadings of a company that is watching its ship sink? The truth is more complicated than that; it turns out. The FDA and Purdue Pharma have a close relationship, although until recently, the FDA may not have realized it. Purdue Pharma operatives were consulted when the FDA created policies that affect the entire nation, often getting the government agency to agree to policies and procedures that limit the manufacturer’s liability. However, the FDA officials didn’t realize that Perdue was paying the people they were consulting with to continue promoting Oxycontin. These operatives were the people consulted when the FDA refused to put limits on how doctors prescribe Oxycontin, meaning that doctors…

Continue Reading